Three drugs that are effective against antibiotic-resistant superbugs, such as MRSA, should be available for use within 2-3 years, according to the British company that discovered them.
They are the first antibiotics employing a novel mode of action to be discovered for more than 30 years. E-Therapeutics, a spin-out company from Newcastle University, used techniques developed under an EPSRC-funded project as part of the UK e-Science Programme to make the discoveries. The drugs are to enter clinical trials next month.
This story has received widespread news coverage, including the front page of the Daily Express (17 January) and on BBC Radio 2.